by Margaret | 2 Apr 2018 | Treatment
The treatment options for Basal Cell Carcinomas will depend upon the age of the individual and the size, location and extent of the lesion. Individuals should talk to their doctor about the different treatment options and which might be best for them. Click on the...
by Margaret | 2 Apr 2018 | Treatment
What is the best treatment for basal cell carcinomas? This is a frequently asked question by many individuals with skin cancer. The age of the individual, underlying medical conditions, type, location and size of the skin cancer are all crucial factors that affect...
by Margaret | 2 Apr 2018 | Treatment
13% of individuals develop a jaw cyst by the age of 10 years and 51% by the age of 20 years. The majority occur after the seventh year. The peak incidence is in the third decade. Misshapen teeth, missing teeth and a susceptibility to caries are more common in...
by Margaret | 12 Aug 2013 | Treatment
Oral treatment Erivedge (vismodegib) now authorised for UK use. Basal Cell Carcinoma (BCC) is the most common form of skin cancer in the UK and is often found on the head and neck. In Gorlin Syndrome individuals can present with multiple BCCs. Erivedge is a major...
by Margaret | 29 Mar 2013 | Treatment
There is a new class of oral agents which inhibit the pathway that is activated in basal cell carcinoma, the hedgehog pathway. (The hedgehog signalling pathway is one of the key regulators of development and gives cells information they need for development). Agents...
by Margaret | 27 Mar 2013 | Treatment
Imiquimod (Aldara) is licensed for the treatment of superficial basal cell carcinomas giving response rates of over 80% when used 5 times a week for 6 weeks. There is little data on its use in individuals with Gorlin Syndrome but from clinical experience it does seem...
